Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Hive (HIVE) vs Injective (INJ) Price & Performance

HiveTrade
InjectiveTrade

Price performance (Past 24H)

Key statistics

Hive vs Injective — how do they compare? Hive trades at Rp891.7 (market cap Rp505,97M, Rp27,67M 24h volume), while Injective trades at Rp92,698 (market cap Rp9,29T, Rp1,78T 24h volume). The key difference: Injective is far larger — about 18360.8× Hive's market cap, and Hive's circulating supply is 567,1M HIVE versus 100M INJ for Injective. Which is the better fit depends on your goals — on Pluang, investors hold Hive for 41 Days and Injective for 36 Days on average.

HIVEINJ
Market Cap
Rp505,97MRp9,29T
Volume (24h)
Rp27,67MRp1,78T
Circulating Supply
567,1M HIVE100M INJ
Typical Hold Time
41 Days36 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Hive

HIVE is currently trading at Rp892.24 with a market cap of Rp503.62M, showing bearish technical signals with moving averages indicating selling pressure while oscillators remain neutral. The token faces immediate resistance at Rp906 and support at Rp871. Recent ecosystem activity includes protocol developments and growing network adoption, though the overall trend remains cautious in the current market environment.

Overall outlook suggests cautious approach with bearish technical bias. Key opportunities lie in potential breakout above resistance levels, while risks include continued selling pressure and market volatility. Investors should monitor support levels closely and consider the neutral oscillator readings before making decisions.

Injective

Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.

Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HIVE
42% Buy58% Sell
Avg holding period · 41 Days
INJ
29% Buy71% Sell
Avg holding period · 36 Days

Top news

Latest headlines on both assets

About Hive

HIVE is a decentralized information sharing network with an accompanying blockchain-based financial ledger built on the Delegated Proof of Stake (DPoS) protocol. Hive is developed to store vast amounts of content and to make it available for time-based monetization. Examples of use include social media with monetized rewards for content producers, interactive games, identity management, polling systems, and micro-loans.

Read more on HIVE

About Injective

Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.

Read more on INJ